2nd Can Ruti Symposium

29 June 2012

Program

Session 1 (10.00-11.30) Chair Miquel A. Gassull

Introduction

Jordi Reverter, IGTP
Epigenetics of thyroid cancer: A joint clinical and basic research project of IGTP and IMPPC
Rafael de Cid, IMPPC
A population based approach for personalized medicine: from genetic medicine to genomic medicine
Antoni Martilla, IGTP
Ataxin-1 modulates protein phosphatase activity 2 (PP2) in spinocerebellar ataxia type 1 (SCA1) neurodegeneration
Ana Rojas, IMPPC
Computational Approaches to Biomedicine

Coffee Break

Session 2 (12.00-13.40) Chair: Marcus Buschbeck

Francesc Solé, IJC
Genetic changes in Myelodysplastic Syndromes 5q- treated with lenalidomide: changes that determine their response to the treatment
Julià Blanco, IGTP
Understanding HIV pathogenesis. The meaning of CD4 and CD8 T cell activation markers
Fumiichiro Yamamoto, IMPPC
Glycosyltransferases and glycosylation
Carolina Armengol, IGTP
Biomarkers in liver cancer

Closure

Top

Generalitat de Catalunya

Unió Europea

CSIC

Universitat Autònoma de Barcelona

Ajuntament de Badalona

Institut Català de la Salut

Germans Trias i Pujol Hospital

Fundació Institut d'investigació en Ciències de la Salut Germans Trias i Pujol